🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 22 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/08/2017 52,29 52,83 51,42 52,64 -0,34% 2,70% 626.500
28/08/2017 53,46 53,75 52,56 52,82 -0,02% 2,23% 695.300
25/08/2017 54,21 54,48 52,62 52,83 -2,18% 3,43% 744.200
24/08/2017 52,16 54,31 51,89 54,01 +3,91% 4,64% 834.400
23/08/2017 52,34 52,45 51,62 51,98 -1,29% 1,59% 739.300
22/08/2017 52,14 52,83 51,48 52,66 +1,02% 2,59% 713.400
21/08/2017 52,11 52,59 50,88 52,13 -0,04% 3,28% 1.105.000
18/08/2017 53,00 53,78 52,07 52,15 -1,83% 3,23% 778.100
17/08/2017 53,63 54,25 53,01 53,12 -0,80% 2,31% 528.700
16/08/2017 54,15 54,59 53,30 53,55 -0,91% 2,38% 827.700
15/08/2017 54,40 54,89 53,57 54,04 +0,11% 2,43% 650.000
14/08/2017 54,64 55,22 53,81 53,98 -0,17% 2,58% 809.900
11/08/2017 53,26 54,66 52,89 54,07 +0,41% 3,32% 705.100
10/08/2017 54,58 54,66 53,27 53,85 -1,70% 2,55% 726.600
09/08/2017 53,47 55,13 53,17 54,78 +2,11% 3,67% 1.043.300
08/08/2017 53,71 54,57 52,71 53,65 -0,28% 3,46% 1.058.000
07/08/2017 52,31 54,25 51,96 53,80 +0,56% 4,38% 1.474.600
04/08/2017 50,00 54,00 49,38 53,50 +9,54% 9,24% 2.836.500
03/08/2017 48,99 48,99 47,24 48,84 +0,58% 3,57% 943.300
02/08/2017 48,04 48,83 47,41 48,56 +1,23% 2,96% 690.000
01/08/2017 48,48 48,48 47,00 47,97 -0,12% 3,05% 620.800
31/07/2017 49,22 49,47 47,93 48,03 -2,89% 3,13% 670.600
28/07/2017 48,66 49,88 48,66 49,46 +1,29% 2,51% 698.000
27/07/2017 49,17 50,75 48,67 48,83 -0,35% 4,23% 1.873.200
26/07/2017 48,93 49,33 48,60 49,00 +0,70% 1,49% 520.700
25/07/2017 48,91 49,75 48,41 48,66 -0,06% 2,74% 829.200
24/07/2017 47,08 48,87 46,72 48,69 +3,44% 4,57% 612.600
21/07/2017 47,90 48,12 46,50 47,07 -1,51% 3,38% 1.019.800
20/07/2017 47,87 48,20 47,42 47,79 +0,13% 1,63% 517.200
19/07/2017 47,89 48,58 47,34 47,73 +0,76% 2,59% 866.300